• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$0.69 $0.14 (25.45%)

REAL-TIME: Last trade at

ARCA Biopharma, Inc.

NASDAQ:ABIO

Jump to this page for:

Related Resources

TIP SHEET: Janus Fund Tries To Manage Risk Of Drug Stocks

4/25/2012 by NASDAQ

GencaroTM's Norepinephrine Lowering Likely Contributes to Its Effect in Atrial Fibrillation Prevention

3/26/2012 by Business Wire

American College of Cardiology to host scientific sessions

3/26/2012 by Theflyonthewall.com

GencaroTM Atrial Fibrillation Data Selected for Presentation at American College of Cardiology 61st Annual Scientific Session & Expo

3/20/2012 by Business Wire

ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient

1/19/2012 by PharmiWeb.com - UK

ARCA Biopharma issued new patent for methods for treatment with bucindolol

1/19/2012 by Theflyonthewall.com

ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genotype of Patient

1/19/2012 by Business Wire

Arca Biopharma (ABIO) Files 2.92M Common Shelf for Shareholders

1/12/2012 by StreetInsider.com

ARCA Biopharma files to sell 2.9M shares of common stock for holders

1/12/2012 by Theflyonthewall.com

CEO of ARCA biopharma to Speak on Use of Biomarkers and Implications of Personalized Medicine at New Paradigms Conference on January 12, 2012

1/5/2012 by PharmiWeb.com - UK

CEO of ARCA biopharma to Speak on Use of Biomarkers and Implications of Personalized Medicine at New Paradigms Conference on January 12, 2012

1/5/2012 by Business Wire

QualityStocks News - ARCA biopharma (ABIO) Receives Patent for Methods of Treatment with Bucindolol

1/3/2012 by PRWeb

ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genetic Targeting

12/30/2011 by PharmiWeb.com - UK

ARCA biopharma (ABIO) Awarded U.S. Patent for Methods of Treatment with Bucindolol

12/30/2011 by StreetInsider.com

ARCA Biopharma announces additional patent issued for Bucindolol treatment

12/30/2011 by Theflyonthewall.com

ARCA biopharma Announces Additional Patent Issued for Methods for Treatment with Bucindolol Based on Genetic Targeting

12/30/2011 by Business Wire

24/7 Wall St. Closing Bell (POT, AGU, SKS, VVUS, MU, AM, CPY, NEOG, TIBX, BBBY, RAM, WCAA, ABIO, PHH, LRE)

12/22/2011 by 24/7 Wall Street

Morning Movers (RAM, WCAA, AKAM, AM, ABIO, VVUS)

12/22/2011 by 24/7 Wall Street

ARCA biopharma Announces Private Placement of $1.75 Million with Institutional Investors

12/22/2011 by PharmiWeb.com - UK

ARCA biopharma (ABIO) Enters 1.75M Unit Private Placement; Sees $1.5M in New Proceeds

12/22/2011 by StreetInsider.com

ARCA Biopharma raises $1.75M in a private placement

12/22/2011 by Theflyonthewall.com

ARCA biopharma Announces Private Placement of $1.75 Million with Institutional Investors

12/22/2011 by Business Wire

ARCA biopharma (ABIO) Reports Substanital Improvement in Onset of Atrial Fibrillation Using Gencaro

11/16/2011 by StreetInsider.com

ARCA Biopharma trading resumes following volatility pause

11/16/2011 by Theflyonthewall.com

ARCA Biopharma announces positive results from Gencaro trial

11/16/2011 by Theflyonthewall.com

GencaroTM Demonstrated 74% Risk Reduction for New Onset Atrial Fibrillation in Heart Failure Patients with Genotype Believed to Be Found in Nearly 50% of Population

11/16/2011 by Business Wire

ARCA BIOPHARMA, INC. Reports Operating Results (10-Q)

11/14/2011 by GuruFocus

GencaroTM Atrial Fibrillation and Pharmacogenetics Presentations at the American Heart Association Scientific Sessions 2011

11/11/2011 by Business Wire

ARCA BIOPHARMA, INC. Reports Operating Results (10-Q)

8/15/2011 by GuruFocus

ARCA Biopharma announces two Gencaro abstracts accepted

8/10/2011 by Theflyonthewall.com

Colorado stocks: Arca, Royal Gold up 2%

7/18/2011 by Denver Business Journal - Denver CO

ARCA Biopharma Announces Planned Expansion Of Gencaro Development To Atrial Fibrillation

5/27/2011 by Medical News Today - UK

ARCA biopharma Announces Planned Expansion of Gencaro Development to Atrial Fibrillation

5/26/2011 by PharmiWeb.com - UK

ARCA biopharma Announces Planned Expansion of Gencaro Development to Atrial Fibrillation

5/26/2011 by Benzinga

ARCA biopharma (ABIO) Exands Gencaro Development into Atrial Fibrillation

5/26/2011 by StreetInsider.com

ARCA Biopharma falls 12.7%

5/17/2011 by Theflyonthewall.com

ARCA BIOPHARMA, INC. Reports Operating Results (10-Q)

5/16/2011 by GuruFocus

Stocks slide; Arca Biopharma up 13%

5/16/2011 by Denver Business Journal - Denver CO

CEO of ARCA biopharma to Present Gencaro Development Programs at the European Society of Cardiology’s Heart Failure Congress 2011

5/16/2011 by PharmiWeb.com - UK

Arca Biopharma raises $5M for drug’s clinical trial

5/13/2011 by Denver Business Journal - Denver CO
See More Articles...